Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Emergent BioSolutions Inc EBS

Healthcare Biotechnology
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a Bioservices portfolio. Its segments include Commercial Products, MCM Products, and Services Segment. Commercial... see more

Recent & Breaking News (NYSE:EBS)

Emergent BioSolutions Advances Program Supporting Licensure of a Post-Exposure Prophylaxis Indication for BioThrax

Business Wire July 10, 2013

Emergent BioSolutions to Release Second Quarter 2013 Financial Results and Conduct a Conference Call on August 5, 2013

Business Wire July 8, 2013

Emergent BioSolutions Receives Paul-Ehrlich-Institut Approval to Market BioThrax in Germany

Business Wire July 1, 2013

Mayor Virg Bernero Leads Ribbon Cutting of Emergent BioSolutions' New Administration Building Representing Another Step in Its Lansing Campus Expansion

Business Wire June 17, 2013

Emergent BioSolutions EVP Corporate Affairs Allen Shofe Appointed to MdBio Foundation Board of Directors

Business Wire June 17, 2013

Emergent BioSolutions to Participate in June and July 2013 Investor Conferences

Business Wire June 6, 2013

Emergent BioSolutions to Webcast Presentation at Jefferies 2013 Global Healthcare Conference

Business Wire May 20, 2013

Emergent BioSolutions to Hold Annual Meeting of Stockholders Thursday May 23, 2013 at 9:00 AM Eastern; Webcast Will Be Available

Business Wire May 16, 2013

Emergent BioSolutions to Webcast Presentation at Bank of America Merrill Lynch 2013 Health Care Conference

Business Wire May 9, 2013

Emergent BioSolutions Presents Preclinical Efficacy Data on ES414 Its Lead ADAPTIR Bispecific Therapeutic for Prostate Cancer

Business Wire May 3, 2013

Emergent BioSolutions Reports Financial Results for First Quarter 2013

Business Wire May 2, 2013

Emergent BioSolutions Participates in NATO Defense against Terrorism Workshop at the Counter Terror Expo in London

Business Wire April 30, 2013

Emergent BioSolutions to Webcast Presentation at Credit Suisse First Annual Antibody Day

Business Wire April 29, 2013

Emergent BioSolutions to Acquire Healthcare Protective Products Division of Bracco Diagnostics Inc.

Business Wire April 25, 2013

Emergent BioSolutions Presents Efficacy Data on ES210; a Bispecific ADAPTIR Molecule for Treating Autoimmune Diseases

Business Wire April 11, 2013

Emergent BioSolutions Announces Positive Preclinical Efficacy and PK Data for Its New Bispecific Adaptir Protein Therapeutic ES414 at AACR

Business Wire April 11, 2013

Emergent BioSolutions to Expand Front Line CLL Clinical Trial of TRU-016 and Rituximab Based on Strong Patient Enrollment and Encouraging Early Clinical Data

Business Wire April 5, 2013

Emergent BioSolutions to Release First Quarter 2013 Financial Results and Conduct a Conference Call on May 2, 2013

Business Wire April 4, 2013

Emergent BioSolutions Reports Financial Results for Fourth Quarter and Full Year 2012

Business Wire March 7, 2013

Emergent BioSolutions to Present at Cowen and Company 33rd Annual Health Care Conference

Business Wire February 11, 2013